Interpretation of correlations between coagulation factors FV, FVIII and vWF in normal and type 2 diabetes mellitus patients

Pakistan Journal of Biological Sciences

Volumn 14, Issue 9, 2011, Pages 552-557

  Dayer, Mohammad Reza ^a   Mard, Maysam Soltani ^b   Dayer, Mohammad Saaid ^c   Alavi, Sayed Mohammad Reza ^a  

^a SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

^b PAYAME NOOR UNIVERSITY   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Coagulation factor; Hypercoagulable states; Statistical correlation; Type 2 dabetes mellitus; Vascular problems

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ARTICLE; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; DIABETIC ANGIOPATHY; FEMALE; FINANCIAL MANAGEMENT; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL ANALYSIS;

CASE-CONTROL STUDIES; COMPETITIVE BIDDING; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FACTOR V; FACTOR VIII; FEMALE; HUMANS; MALE; MIDDLE AGED; VON WILLEBRAND FACTOR;

MLCS; MLOWN;

EID: 84856379779     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2011.552.557     Document Type: Article

References (22)

1. Asselta, R. and F. Peyvandi, 2009. Factor V deficiency. Semin. Thromb. Hemost., 35: 382-389.
2. Asselta, R., M.L. Tenchini and S. Duga, 2006. Inherited defects of coagulation factor V: The hemorrhagic side. J. Thromb. Haemost., 4: 26-34.
3. Behnam-Rassouli, M., M.B. Ghayour and N. Ghayour, 2010. Microvascular complications of diabetes. J. Biol. Sci., 10: 411-423.
4. Bowen, D.J., R.M. Maclean, S. Pellard and P.W. Collins, 2001. High concentrations of coagulation factor VIII and thrombosis: Is the factor VIII-binding domain of von Willebrand factor implicated?. Br. J. Haematol., 113: 655-657.
5. Camire, R.M. and M.H. Bos, 2009. The molecular basis of factor V and VIII procofactor activation. J. Thromb. Haemost., 7: 1951-1961.
6. Duffy, T.C., R. Kirby and E. Rudloff, 2004. Critical role of the vascular endothelial cell in health and disease: A review article. J. Vet. Emerg. Crit. Care, 14: 84-99.
7. Eikenboom, J.C., G. Castaman, P.W. Kamphuisen, F.R. Rosendaal and R.M. Bertina, 2002. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor. Thromb. Haemost., 87: 252-257.
8. Fang, H., L. Wang and H. Wang, 2007. The protein structure and effect of factor VIII. Thromb. Res., 119: 1-13.
9. Fuentes-Prior, P., K. Fujikawa and K.P. Pratt, 2002. New insights into binding interfaces of coagulation factors V and VIII and their homologues lessons from high resolution crystal structures. Curr. Protein Pept. Sci., 3: 313-339.
10. Hajifathali, A., B. Kazemi, A. Pourfathollah, G.R. Lari and R. Chegeni, 2005. Coagulation factor V mutations in iranian patients with venous thrombosis. Pak. J. Biol. Sci., 8: 1272-1274.
11. Hameed, A., S.A. Malik, F. Rabbi, A. Sharif and N. Ahmad et al., 2002. Diabetic complications: Influence of age, sex, family history, duration, glycemic control and obesity. J. Biol. Sci., 2: 710-714.
12. Ma, E.S., C.L. Wong, H.Y. Lam, C.L. Wang and S.Y. Ma, 2007. Combined factors V and VIII deficiency (F5F8D) in a Chinese family due to compound heterozygosity for nonsense mutations of the LMAN1 gene. Br. J. Haematol., 139: 509-511.
13. Mard-Soltani, M., M.R. Dayer, G. Ataie, A.A. Moazedi, M.S. Dayer and S.M.R. Alavi, 2011. Coagulation factors evaluation in NIDDM patients. Am. J. Biochem. Mol. Biol., 1: 244-254.
14. Ni Ainle, F., R.J. Preston, P.V. Jenkins, H.J. Nel and J.A. Johnson et al., 2009. Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation. Blood, 114: 1658-1665.
15. Pipe, S.W., 2009. Functional roles of the factor VIII B domain. Haemophilia, 15: 1187-1196.
16. Rezaeian, Z., G. Torkman, F. Nad-ali, R. Ravanbod and A.A. Pourfathollah et al., 2006. Effect of physical fitness on the coagulant activity of healthy young men. Pak. J. Biol. Sci., 9: 2032-2039.
17. Rondaij, M.G., R. Bierings, E.L. van Agtmaal, K.A. Gijzen and E. Sellink et al., 2008. Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade bodies from endothelial cells. Blood, 112: 56-63.
18. Suzuki, H., M. Shima, K. Nogami, Y. Sakurai and K. Nishiya et al., 2006. Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activation. J. Thromb. Haemost., 4: 1354-1360.
19. Van den Biggelaar, M., A.B. Meijer, J. Voorberg and K. Mertens, 2009. Intracellular cotrafficking of factor VIII and von Willebrand factor type 2N variants to storage organelles. Blood, 113: 3102-3109.
20. Van den Biggelaar, M., E.A.M. Bouwens, N.A. Kootstra, R.P. Hebbel, J. Voorberg and K. Mertens, 2009. Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells. Haematologica, 94: 670-678.
21. Wigren, E., J.M. Bourhis, I. Kursula, J.E. Guy and Y. Lindqvist, 2010. Crystal structure of the LMAN1-CRD/MCFD2 transport receptor complex provides insight into combined deficiency of factor V and factor VIII. FEBS Lett., 584: 878-882.
22. Zheng, C., H.H. Liu, S. Yuan, J. Zhou and B. Zhang, 2010. Molecular basis of LMAN1 in coordinating LMAN1-MCFD2 cargo receptor formation and ER-to-Golgi transport of FV/FVIII. Blood, 116: 5698-5706.